XML 63 R44.htm IDEA: XBRL DOCUMENT v3.24.0.1

OPTIONS AND AWARDS (Tables)

12 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Assumptions for Stock Options Granted

The Company used the following assumptions for stock options granted during the years ended December 31, 2023, 2022 and 2021:

Grant Year						Options Granted						Weighted Average Risk-Free Rate						Expected Life						Weighted Average Volatility						Weighted Average Dividend Yield
2023						1,008						4.3%						6.2 years						41.3%						0.2%
2022						581						2.8%						6.2 years						42.1%						0.3%
2021						621						1.0%						6.2 years						42.4%						0.3%

Schedule of Exercise Price and Fair Value Displayed at Grant Date for Stock Option Grants

For the years ended December 31, 2023, 2022 and 2021, the following represents the exercise price and fair value displayed at grant date for stock option grants:

Grant Year						Granted						Weighted Average Exercise Price						Weighted Average Fair Value of Options
2023						1,008						$	95.05					$	43.85
2022						581						$	85.74					$	37.83
2021						621						$	80.19					$	32.82

Schedule of Employee Stock Option Roll Forward

The following table represents the employee stock option activity during the year ended December 31, 2023:

			Number of Options Outstanding						Weighted Average Exercise Price						Number of Options Vested						Weighted Average Exercise Price of Options Vested
January 1, 2021			4,038						$	27.71					2,148						$	16.66
Granted			621						80.19
Forfeited			(105)						44.76
Exercised			(516)						17.80
December 31, 2021			4,038						$	36.60					2,183						$	21.02
Granted			581						85.74
Forfeited			(98)						59.52
Exercised			(688)						18.43
December 31, 2022			3,833						$	46.72					2,069						$	28.87
Granted			1,008						95.05
Forfeited			(91)						71.44
Exercised			(759)						24.21
December 31, 2023			3,991						$	62.65					1,887						$	39.58

Stock Options Outstanding, Vested and Related Details

The following summary information reflects stock options outstanding, vested and related details as of December 31, 2023:

						Stock Options Outstanding																														Stock Options Vested
																		Number Outstanding						Black-Scholes Fair Value						Remaining Contractual Life (Years)						Vested and Exercisable
Year of Grant						Exercise Price
2014						8.94			-			16.05						99						$	484					1						99
2015						18.20			-			21.39						175						1,369						2						175
2016						15.93			-			16.86						155						916						3						155
2017						15.80			-			19.41						194						1,138						4						194
2018						22.49			-			32.71						336						3,523						5						336
2019						41.07			-			45.76						510						8,014						6						383
2020						44.84			-			59.49						476						9,383						7						257
2021						73.47			-			83.64						513						16,844						8						189
2022						79.79			-			94.88						540						20,466						9						99
2023						$89.83			-			$98.83						993						43,566						10						—
TOTAL																		3,991						$	105,703											1,887

Schedule of Aggregate Intrinsic Value of Options

The aggregate intrinsic value of options outstanding, vested and expected to vest as of December 31, 2023, 2022 and 2021 is as follows:

						December 31,
Options						2023						2022						2021
Outstanding						$	197,819					$	183,593					$	191,242
Vested						137,048						136,000						137,382
Expected to vest						56,759						43,232						48,548

Schedule of Nonvested Restricted Stock Awards

			Non-Vested Restricted Awards						Weighted Average Grant Date Fair Value
Nonvested at January 1, 2021			591						$	38.90
Granted			222						81.65
Vested			(244)						47.45
Forfeited			(20)						45.64
Nonvested at December 31, 2021			549						$	52.16
Granted			233						81.57
Vested			(269)						54.06
Forfeited			(26)						57.29
Nonvested at December 31, 2022			487						$	64.92
Granted			219						92.04
Vested			(255)						64.21
Forfeited			(20)						71.53
Nonvested at December 31, 2023			431						$	78.91

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense recognized for the Company's equity incentive plans and long-term incentive plan for the years ended December 31, 2023, 2022 and 2021 was as follows:

									Year Ended December 31,
															2023						2022						2021
Stock-based compensation expense related to stock options															$	17,221					$	11,361					$	8,459
Stock-based compensation expense related to restricted stock awards															11,845						9,920						8,385
Stock-based compensation expense related to stock options and restricted stock awards to non-employee directors															1,688						1,439						1,834
TOTAL															$	30,754					$	22,720					$	18,678

X

- References

No definition available.

+ Details

Name:	us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the change in common stock outstanding.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the changes in outstanding nonvested restricted stock units.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (c)(2)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (f)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the weighted-average grant-date fair value of equity options or other equity instruments granted during the year.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (d)(1)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for exercisable or convertible options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (e)(2)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration